News

Here's what to know about the FDA's COVID-19 vaccine changes
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
WebMD6d
COVID Vaccine Guidance May Change: 3 Things to Know Right Now
See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the ...
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...
Biden officials knew about potential COVID-19 vaccine risks — and took steps to downplay them: scathing Senate report
Federal health agencies were alerted in February 2021 to “large reports of myocarditis” in young people who received the Pfizer vaccine, but waited until late June to adjust the ...
GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Healio2d
FDA committee recommends formula for fall COVID-19 vaccines
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
Devdiscourse7d
Novavax's COVID-19 Vaccine Receives FDA Approval with Limitations
The U.S. FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, for older adults and those aged 12 to 64 at risk of severe illness. Despite missed deadlines and regulatory challenges, the approval is ...